The atrial septal defect diagnosed in the senility – the benefit of the transcatheter closure (RCD code: IV‑2B.1)

Monika Komar, Tadeusz Przewlocki, Bartosz Sobień, Urszula Gancarczyk, Paweł Prochownik, Piotr Wilkołek, Maria Olszowska, Piotr Podolec

Full Text:



Objective: Closure of the atrial septal defect in the elderly patients is controversial. The aim of the study was to evaluate the outcomes of transcatheter closure of secundum atrial septal defect (ASD) in elderly patients. Methods: From a total of 488 patients with ASD who underwent transcatheter closure 15 pts over 70 years (10 females, 5 males) with a mean age of 75.3 ±12.7 (70–79) were analyzed. All patients had an isolated secundum ASD with a mean Qp:Qs: 3.01 ±1.9 (2.6–3.9). A symptom-limited treadmill exercise tests with respiratory gas exchange analysis and transthoracic color Doppler echocardiographic study as well as Quality of life (QoL) measured using the SF36 questionnaire (SF36q) were repeated in all patients before procedure and after 12 months of follow-up. Results: The atrial septal occluder (ASO) device was successfully implanted in all patients (procedure time 29.7±6.5 (14–59) minutes, fluoroscopy time 13.2 ±9.3(6–40) minutes). There were no major complications. The defect echo diameter was 21.7± 15.8 (18–33) mm. The diameter of the implanted devices ranged 20 – 36 mm. After 12 months of ASD closure, all the patients showed a significant improvement of exercise capacity parameters. Seven QoL parameters (except mental health) improved at 12 months follow up compared to their baseline data. The right ventricular dimension decreased (p<0.005), parameters of exercise capacity improved – oxygen consumption increased (p<0.001). Conclusions: Closure of ASD in elderly patients caused a significant clinical and hemodynamic improvement after percutaneous treatment, which is maintained to long-term follow-up what justified this procedure in old age. JRCD 2015; 2 (5): 144–149


atrial septal defect, transcatheter closure, elderly, cardiopulmonary exercise test, quality of life


Campbell M. Natural history of atrial septal defect. Br Heart J. 1970; 32: 820–826.

Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002; 39: 1890–1900.

Murphy JG, Gersh BJ, McGoon MD et al. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 1990; 323: 1645–1650

Butera G, Carminati M, Chessa M, et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006; 151: 228–234.

Fischer G, Stieh J, Uebing A, et al. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart 2003; 89: 199–204.

Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496–502. 7. Harjula A, Kupari M, Kyösola K, et al. Early and late results of surgery for atrial septal defect in patients aged over 60 years. J Cardiovasc Surg (Torino) 1988; 29: 134–139.

Miyaji K, Furuse A, Tanaka O, et al. Surgical repair for atrial septal defect in patients over 70 years of age. Jpn Heart J. 1997; 38: 677–684.

Attie F, Rosas M, Granados N, et al. Surgical treatment for secundum atrial septal defects in patients.40 years old. A randomized clinical trial. J Am Coll Cardiol 2001; 38: 2035–2042. 10. Białkowski J, Szkutnik M, Wilczek K, et al. Transcatheter closure of atrial septal defects in adults with the Amplatzer atrial septal occluder. Pol Arch Med Wewn. 2001; 105: 303–309.

Attie F, Rosas M, Granados N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol. 2001; 38: 2035–2042. 12. Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999; 68: 75–78.

Alfakih K, Plein S, Thiele H, et al. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging. 2003; 17: 323–329.

Hauser TH, McClennen S, Katsimaglis G ,et al. Assessment of left atrial volume by contrast enhanced magnetic resonance angiography. J Cardiovasc Magn Reson. 2004; 6: 491–497.

Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv. 2002; 57: 508–524.

Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am. Coll. Cardiol. 2005; 45: 505 – 507. 17. Veldtman GR, Razack V, Siu S, et al. Right ventricular form and function after percutaneous atrial septal defect device closure. J Am. Coll. Cardiol. Jun 2001; 37: 2108–2113.

Galal MO, Wobst A, Halees Z, et al. Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients – a baseline study. Eur Heart J. 1994; 15: 1381–1384. 19. Brochu MC, Baril JF, Dore A, et al. Improvement in exercise capacity in asymptomatic and mildly symptomatic adults after atrial septal defect percutaneous closure. Circulation. 2002; 106: 1821–1826.

Roos-Hesselink JW, Meijboom FJ, Spitaels SE, et al. Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21–33 years. Eur Heart J. 2003; 24: 190–197.

Attie F, Rosas M, Granados N, et al. Surgical treatment for secundum atrial septal defects in patients >40 years old. A randomized clinical trial. J Am Coll Cardiol. 2001; 38: 2035–2042. 22. Horvath KA, Burke RP, Collins JJ, et al. Surgical treatment of adult atrial septal defect; early and long-term results J Am Coll Cardiol 1992; 20: 1156–1159

Yüce M, Ozer O, Cakıcı M, et al. Closure of secundum atrial septal defects by the Amplatzer occluder device. Turk Kardiyol Dern Ars. 2011; 39: 35–40.

Gierat-Haponiuk K, Haponiuk I, Szalewska D, et al. Effect of complex cardiac rehabilitation on physical activity and quality of life during long-term followup after surgical correction of congenital heart disease. Kardiol Pol. 2015; 73: 267–273.



  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659